Ameriprise Financial Inc. cut its stake in shares of Colgate-Palmolive Company (NYSE:CL) by 65.5% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 459,544 shares of the company’s stock after selling 873,458 shares during the period. Ameriprise Financial Inc. owned about 0.05% of Colgate-Palmolive worth $34,066,000 as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of CL. Buckingham Asset Management LLC lifted its stake in Colgate-Palmolive by 13.7% during the 1st quarter. Buckingham Asset Management LLC now owns 17,031 shares of the company’s stock valued at $1,246,000 after acquiring an additional 2,046 shares in the last quarter. Heritage Trust Co bought a new position in Colgate-Palmolive during the 1st quarter valued at $146,000. Ffcm LLC lifted its stake in Colgate-Palmolive by 7.3% during the 1st quarter. Ffcm LLC now owns 47,077 shares of the company’s stock valued at $3,446,000 after acquiring an additional 3,217 shares in the last quarter. Norinchukin Bank The lifted its stake in Colgate-Palmolive by 2.2% during the 1st quarter. Norinchukin Bank The now owns 428,624 shares of the company’s stock valued at $31,371,000 after acquiring an additional 9,050 shares in the last quarter. Finally, Mark Sheptoff Financial Planning LLC lifted its stake in Colgate-Palmolive by 12.9% during the 1st quarter. Mark Sheptoff Financial Planning LLC now owns 26,251 shares of the company’s stock valued at $1,921,000 after acquiring an additional 3,001 shares in the last quarter. Institutional investors and hedge funds own 73.87% of the company’s stock.

In other Colgate-Palmolive news, insider Victoria L. Dolan sold 9,000 shares of Colgate-Palmolive stock in a transaction dated Tuesday, November 14th. The stock was sold at an average price of $73.41, for a total transaction of $660,690.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, CMO Mukul Deoras sold 7,500 shares of Colgate-Palmolive stock in a transaction dated Friday, November 10th. The shares were sold at an average price of $73.28, for a total value of $549,600.00. Following the transaction, the chief marketing officer now directly owns 45,217 shares of the company’s stock, valued at approximately $3,313,501.76. The disclosure for this sale can be found here. Insiders sold a total of 173,673 shares of company stock worth $12,629,293 over the last 90 days. 1.02% of the stock is currently owned by company insiders.

ILLEGAL ACTIVITY NOTICE: “Colgate-Palmolive Company (CL) Holdings Trimmed by Ameriprise Financial Inc.” was published by Daily Political and is owned by of Daily Political. If you are viewing this news story on another site, it was illegally copied and republished in violation of United States & international trademark & copyright laws. The original version of this news story can be viewed at https://www.dailypolitical.com/2017/11/17/colgate-palmolive-company-cl-holdings-trimmed-by-ameriprise-financial-inc.html.

Several brokerages have weighed in on CL. Zacks Investment Research upgraded Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $80.00 price objective on the stock in a research note on Monday, September 25th. Royal Bank Of Canada restated a “hold” rating and set a $74.00 price objective on shares of Colgate-Palmolive in a research note on Sunday, October 8th. Deutsche Bank AG restated a “hold” rating and set a $75.00 price objective on shares of Colgate-Palmolive in a research note on Monday, July 24th. Wells Fargo & Company reiterated a “market perform” rating on shares of Colgate-Palmolive in a research note on Monday, July 24th. Finally, Macquarie initiated coverage on Colgate-Palmolive in a research note on Thursday, September 14th. They set a “neutral” rating and a $76.00 target price on the stock. One investment analyst has rated the stock with a sell rating, fifteen have issued a hold rating and four have issued a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and a consensus target price of $76.67.

Shares of Colgate-Palmolive Company (CL) opened at $72.63 on Friday. Colgate-Palmolive Company has a 52 week low of $63.43 and a 52 week high of $77.27. The stock has a market capitalization of $63,645.07, a PE ratio of 25.25, a P/E/G ratio of 3.32 and a beta of 0.80. The company has a quick ratio of 0.92, a current ratio of 1.23 and a debt-to-equity ratio of 24.42.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings data on Friday, October 27th. The company reported $0.73 earnings per share (EPS) for the quarter, meeting the Zacks’ consensus estimate of $0.73. Colgate-Palmolive had a return on equity of 2,782.56% and a net margin of 15.10%. The business had revenue of $3.97 billion for the quarter, compared to analysts’ expectations of $3.94 billion. During the same period in the previous year, the business posted $0.73 EPS. The firm’s quarterly revenue was up 2.8% compared to the same quarter last year. equities analysts anticipate that Colgate-Palmolive Company will post 2.88 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, November 15th. Investors of record on Monday, October 23rd were paid a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a yield of 2.20%. The ex-dividend date of this dividend was Friday, October 20th. Colgate-Palmolive’s dividend payout ratio is currently 61.78%.

Colgate-Palmolive Profile

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Company and related companies with MarketBeat.com's FREE daily email newsletter.